Alpha-fetoprotein and highly active antiretroviral therapy in patients coinfected with HIV-1 and hepatitis C virus

Affiliations

Case Reports

N Tachikawa et al. Eur J Clin Microbiol Infect Dis. 2001 May.

. 2001 May;20(5):364-6.

doi: 10.1007/s100960100492.

No abstract available

Similar articles

The influence of hepatitis C virus coinfection on the risk of lipid abnormalities in a cohort of HIV-1-infected patients after initiation of highly active antiretroviral therapy.
Di Giambenedetto S, Baldini F, Cingolani A, Tamburrini E, Cauda R, De Luca A. Di Giambenedetto S, et al. J Acquir Immune Defic Syndr. 2004 May 1;36(1):641-2. doi: 10.1097/00126334-200405010-00015. J Acquir Immune Defic Syndr. 2004. PMID: 15097310 No abstract available.
Resolution of HCV infection after highly active antiretroviral therapy in a HIV-HCV coinfected patient.
De Rosa FG, Audagnotto S, Bargiacchi O, Garazzino S, Aguilar Marucco D, Veronese L, Canta F, Bonora S, Sinicco A, Di Perri G. De Rosa FG, et al. J Infect. 2006 Nov;53(5):e215-8. doi: 10.1016/j.jinf.2006.01.023. Epub 2006 Mar 20. J Infect. 2006. PMID: 16549201
Co-infections. Can hepatitis C virus help keep cholesterol levels low?
[No authors listed] [No authors listed] TreatmentUpdate. 2006 Oct-Nov;18(5):4-5. TreatmentUpdate. 2006. PMID: 17205648 No abstract available.
Challenges for hepatitis C patients coinfected with HIV.
Bruno R, Cotler S, Sacchi P, Ciappina V, Rondanelli M, Filice G. Bruno R, et al. Am Clin Lab. 2002 Apr;21(3):26-31. Am Clin Lab. 2002. PMID: 12038082 Review. No abstract available.
Therapy of hepatitis C in HIV-coinfection.
Rockstroh JK, Vogel M. Rockstroh JK, et al. Eur J Med Res. 2004 Jun 30;9(6):304-8. Eur J Med Res. 2004. PMID: 15257871 Review.